Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Teligent EBIT Margin 2010-2021 | TLGT

Current and historical EBIT (Earnings Before Interest & Taxes) margin for Teligent (TLGT) over the last 10 years. The current EBIT profit margin for Teligent as of June 30, 2021 is .
  
Teligent EBIT Margin Historical Data
Date TTM Revenue TTM EBIT EBIT Margin
2021-06-30 $0.05B $-0.14B -300.00%
2021-03-31 $0.05B $-0.13B -262.00%
2020-12-31 $0.05B $-0.14B -311.11%
2020-09-30 $0.05B $-0.04B -72.55%
2020-06-30 $0.06B $-0.03B -50.91%
2020-03-31 $0.06B $-0.02B -38.98%
2019-12-31 $0.07B $-0.01B -12.31%
2019-09-30 $0.07B $-0.01B -10.61%
2019-06-30 $0.07B $-0.01B -12.12%
2019-03-31 $0.06B $-0.01B -21.88%
2018-12-31 $0.07B $-0.02B -22.73%
2018-09-30 $0.06B $-0.02B -28.33%
2018-06-30 $0.05B $-0.02B -45.28%
2018-03-31 $0.06B $-0.02B -34.55%
2017-12-31 $0.06B $-0.01B -20.00%
2017-09-30 $0.06B $-0.01B -7.94%
2017-06-30 $0.07B $0.00B 4.41%
2017-03-31 $0.07B $0.00B 5.97%
2016-12-31 $0.06B $0.00B 3.17%
2016-09-30 $0.06B $-0.00B -1.61%
2016-06-30 $0.06B $-0.00B -1.72%
2016-03-31 $0.05B $-0.00B -8.00%
2015-12-31 $0.05B $-0.00B -8.89%
2015-09-30 $0.05B $0.00B 6.52%
2015-06-30 $0.04B $0.00B 7.32%
2015-03-31 $0.04B $0.01B 13.16%
2014-12-31 $0.03B $0.00B 11.76%
2014-09-30 $0.03B $0.00B 3.70%
2014-06-30 $0.02B $0.00B 4.17%
2014-03-31 $0.02B $0.00B 4.55%
2013-12-31 $0.02B $0.00B 5.26%
2013-09-30 $0.01B $-0.00B -7.14%
2013-06-30 $0.01B $-0.00B -16.67%
2013-03-31 $0.01B $-0.00B -30.00%
2012-12-31 $0.01B $-0.00B -50.00%
2012-09-30 $0.01B $-0.00B -50.00%
2012-06-30 $0.01B $-0.00B -37.50%
2012-03-31 $0.01B $-0.00B -37.50%
2011-12-31 $0.01B $-0.00B -37.50%
2011-09-30 $0.01B $-0.00B -37.50%
2011-06-30 $0.01B $-0.00B -50.00%
2011-03-31 $0.01B $-0.00B -50.00%
2010-12-31 $0.01B $-0.00B -57.14%
2010-09-30 $0.01B $-0.00B -66.67%
2010-06-30 $0.01B $-0.00B -80.00%
2010-03-31 $0.00B $-0.00B -100.00%
2009-12-31 $0.00B $-0.00B -100.00%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.000B
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $15.751B 5.69
Dr Reddy's Laboratories (RDY) India $12.261B 19.39
Aspen Pharmacare (APNHY) South Africa $5.328B 0.00
BridgeBio Pharma (BBIO) United States $4.794B 0.00
Bausch Health Cos (BHC) Canada $3.201B 2.50
Amphastar Pharmaceuticals (AMPH) United States $2.016B 13.80
Supernus Pharmaceuticals (SUPN) United States $1.655B 0.00
Taysha Gene Therapies (TSHA) United States $0.454B 0.00
Generation Bio (GBIO) United States $0.188B 0.00
Personalis (PSNL) United States $0.074B 0.00
Assembly Biosciences (ASMB) United States $0.068B 0.00
Acasti Pharma (ACST) Canada $0.026B 0.00
Sol-Gel Technologies (SLGL) Israel $0.020B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00